Compare the clinical efficacy of oral gabapentin and naproxen on the severity of bone and joint pain in brucellosis patients

Phase 3

Recruiting

• Conditions: Brucellosis.; Brucellosis, unspecified

• Registration Number: IRCT20171124037609N1
• Lead Sponsor: Shahroud University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 86

Inclusion Criteria

Definitive diagnosis of brucellosis
There is no history of systemic disease (such as diabetes or thyroid disease), vascular diseases, coagulation problems (eg hemophilia), history of gastrointestinal bleeding and structural disorders (scoliosis and spondylolisthesis, etc.)
No neurological symptoms such as SLR and Cross-SLR, decreased tendin reflexes and decreased sensation in examination
Age range 15 to 65 years
Complaint of severe and Fairly intense bone and joint pain
Desire and satisfaction to enter the study

Exclusion Criteria

Corticosteroid injections in the lumbar region or other areas of the body within 3 months before and during the study
Dissatisfaction to continue treatment
Those who use drugs
A history of back pain or repetitive back pain is more than 4 times a year
Taking multiple medications for other illnesses (such as hypnotics, anti-leptic, relaxants)
Severe hypersensitivity to any of the two drugs, gabapentin and naproxen
Dissatisfaction with cooperation and participation in the project

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Intensity of pain. Timepoint: On the third, fifth and seventh day after the intervention. Method of measurement: Visual Analog Scale.